244
Participants
Start Date
August 18, 2017
Primary Completion Date
June 10, 2019
Study Completion Date
July 31, 2019
bicyclol tablet 25mg
Patients in the low dose group administrated bicyclol tablet 25mg, one bicyclol blank analog tablet and two polyene phosphatidylcholine blank analog capsules orally, three times daily for 4-8 weeks.
bicyclol tablet 50mg
Patients in the high dose group administrated bicyclol tablet 50mg and two polyene phosphatidylcholine blank analog capsules orally, three times daily for 4-8 weeks.
polyene phosphatidylcholine capsule 456mg
Patients in the positive drug control group administrated polyene phosphatidylcholine capsules 456mg and two bicyclol blank analog tablets orally, three times daily for 4-8 weeks.
Beijing Chest Hospital, Capital Medical University, Beijing
Renji Hospital ，Shanghai Jiao Tong University School of Medicine, Shanghai
Fuzhou General Hospital of Nanjing Military Command, Fuzhou
Anhui Provincial Hospital, Hefei
Beijing Ditan Hospital, Capital Medical University, Beijing
The second affiliated Hospital of Chongqing Medical University, Chongqing
The First affiliated Hospital of Xinxiang Medical University, Weihui
Henan Infectious Diseases Hospital, Zhengzhou
Henan Provincial People's Hospital, Zhengzhou
The Second Xiangya Hospital of Central South University, Changsha
Jiangsu Province Hospital, Nanjing
No.85 hospital of PLA, Shanghai
Ruijin Hospital ，Shanghai Jiao Tong University School of Medicine, Shanghai
Shanghai Putuo District Central Hospital, Shanghai
Tongji Hospital of Tongji University, Shanghai
Tianjin Haihe Hospital, Tianjin
Shanghai Lung Hospital, Shanghai
Collaborators (1)
Beijing Union Pharmaceutical Factory Ltd
INDUSTRY
Drug Induced Liver Disease Study Group
OTHER